1. Home
  2. NKTR vs RCAT Comparison

NKTR vs RCAT Comparison

Compare NKTR & RCAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nektar Therapeutics

NKTR

Nektar Therapeutics

HOLD

Current Price

$36.98

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Logo Red Cat Holdings Inc.

RCAT

Red Cat Holdings Inc.

BUY

Current Price

$4.29

Market Cap

1.3B

Sector

Industrials

ML Signal

BUY

Company Overview

Basic Information
Metric
NKTR
RCAT
Founded
1990
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Wholesale Distributors
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.3B
IPO Year
1996
2017

Fundamental Metrics

Financial Performance
Metric
NKTR
RCAT
Price
$36.98
$4.29
Analyst Decision
Buy
Strong Buy
Analyst Count
15
8
Target Price
★ $133.08
$16.50
AVG Volume (30 Days)
1.4M
★ 5.5M
Earning Date
11-05-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $307,711,000.00
$17,836,382.00
Revenue This Year
N/A
$270.70
Revenue Next Year
$30.00
$45.18
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 86.00
79.95
52 Week Low
$33.40
$4.27
52 Week High
$109.00
$18.78

Technical Indicators

Market Signals
Indicator
NKTR
RCAT
Relative Strength Index (RSI) 29.12 17.63
Support Level $34.45 N/A
Resistance Level $39.59 $11.75
Average True Range (ATR) 1.98 0.31
MACD 0.66 -0.04
Stochastic Oscillator 22.11 6.57

Price Performance

Historical Comparison
NKTR
RCAT

About NKTR Nektar Therapeutics

Nektar Therapeutics is a clinical-stage, research-based biopharmaceutical company headquartered in San Francisco, California, and incorporated in Delaware, focused on discovering and developing medicines in the field of immunotherapy. The Company directs its efforts toward creating immunomodulatory agents that selectively induce, amplify, attenuate, or prevent immune responses to achieve desired therapeutic outcomes. Its pipeline of clinical-stage and preclinical-stage immunomodulatory agents targets the treatment of autoimmune diseases, including rezpegaldesleukin, NKTR-0165, NKTR-0166, and NKTR-422, as well as cancer, including NKTR-255.

About RCAT Red Cat Holdings Inc.

Red Cat Holdings Inc is a drone technology company integrating robotic hardware and software for military, government, and commercial operations. Its suite of solutions includes the Arachnid family of ISR and precision strike drones, which includes the Black Widow, a small unmanned ISR system; and WEB (Warfighter Electronic Bridge) GCS, designed to command and control an entire drone family of systems for military operations. Its other offerings include Edge 130 Blue drone systems, Trichon, a fixed-wing VTOL for extended endurance and range, and FANG FPV drones optimized for military operations with precision strike capabilities. The firm's Division includes Teal, FlightWave, and Blue Ops.

Share on Social Networks: